Evidence map›Paper›PMID 35134329›Full record

ArticleCurrent biology : CB2022

A bacterial endosymbiont of the fungus Rhizopus microsporus drives phagocyte evasion and opportunistic virulence.

Herbert Itabangi, Poppy C S Sephton-Clark, Diana P Tamayo, Xin Zhou, Georgina P Starling, Zamzam Mahamoud, Ignacio Insua, Mark Probert, Joao Correia, Patrick J Moynihan and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Current biology : CB, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Phylogenetically diverse MucoralesMicrobial genomics · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Lineage-specific endosymbiosis in Mucorales: restriction ofCurrent research in microbial sciences · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Endobacteria Have a Negative Effect on the Virulence ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  14. Article
  15. Review
  16. Pathogens (Basel, Switzerland) · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Herbert ItabangiInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Poppy C S Sephton-ClarkInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Diana P TamayoMRC Centre for Medical Mycology, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter, EX4 4QD, UK.
Xin ZhouInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Georgina P StarlingSchool of Biosciences, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.
Zamzam MahamoudSchool of Biosciences, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.
Ignacio InsuaSchool of Chemistry, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.
Mark ProbertInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Joao CorreiaInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Patrick J MoynihanInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Teclegiorgis GebremariamThe Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
Yiyou GuThe Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.
Ashraf S IbrahimThe Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Gordon D BrownMRC Centre for Medical Mycology, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter, EX4 4QD, UK.
Jason S KingSchool of Biosciences, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK. Electronic address: jason.king@sheffield.ac.uk.
Elizabeth R BallouInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; MRC Centre for Medical Mycology, University of Exeter, Geoffrey Pope Building, Stocker Road, Exeter, EX4 4QD, UK. Electronic address: e.ballou@exeter.ac.uk.
Kerstin VoelzInstitute of Microbiology and Infection, School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: dr.kerstin.voelz@gmail.com.
University of Birmingham · GBUniversity of Exeter · GBUniversity of Sheffield · GBUCLA Medical Center · USUniversity of California, Los Angeles · US

Funding

Novel Toxins and Receptors in Mucormycosis Pathogenesis and TreatmentR01AI063503 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI IBRAHIM, ASHRAF S. · 2006 to 2025
$7.3M
Biotechnology and Biological Sciences Research Council BB/M01116X/1Biotechnology and Biological Sciences Research Council BB/M014525/1Biotechnology and Biological Sciences Research Council BB/S010122/1Medical Research Council MR/N006364/2Medical Research Council MR/V033417/1NIAID NIH HHS R01 AI063503Wellcome Trust 097377Wellcome Trust 102705Wellcome Trust 102705/Z/13/ZWellcome Trust 108387/Z/15/ZWellcome Trust 211241/Z/18/Z
6 · The paper itself

Abstract

Opportunistic infections by environmental fungi are a growing clinical problem, driven by an increasing population of people with immunocompromising conditions. Spores of the Mucorales order are ubiquitous in the environment but can also cause acute invasive infections in humans through germination and evasion of the mammalian host immune system. How they achieve this and the evolutionary drivers underlying the acquisition of virulence mechanisms are poorly understood. Here, we show that a clinical isolate of Rhizopus microsporus contains a Ralstonia pickettii bacterial endosymbiont required for virulence in both zebrafish and mice and that this endosymbiosis enables the secretion of factors that potently suppress growth of the soil amoeba Dictyostelium discoideum, as well as their ability to engulf and kill other microbes. As amoebas are natural environmental predators of both bacteria and fungi, we propose that this tri-kingdom interaction contributes to establishing endosymbiosis and the acquisition of anti-phagocyte activity. Importantly, we show that this activity also protects fungal spores from phagocytosis and clearance by human macrophages, and endosymbiont removal renders the fungal spores avirulent in vivo. Together, these findings describe a new role for a bacterial endosymbiont in Rhizopus microsporus pathogenesis in animals and suggest a mechanism of virulence acquisition through environmental interactions with amoebas.

Indexed as

AmoebaDictyosteliumAnimalsBacteriaFungiHumansMammalsMicePhagocytesRhizopusVirulenceZebrafishDictyosteliumendosymbiosisevolutionfungal pathogenesisMurcomyceteRalstoniaRhizopussoil microbiology

Identifiers

PMID35134329
PMCPMC8926845
OpenAlexW4210836132

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.